Gardp North America Inc
- Assets
- $898.6k
- Revenue
- $1.1m
- Investments
- $0.0
- Employees
- 2
- Location
- Philadelphia, PA
- Founding
- Data as of
- 12/2021
- EIN
- 86-4001361
Organization Overview
Gardp North America Inc is located in Philadelphia, PA. According to its NTEE Classification (H92) the organization is classified as: Biomedicine & Bioengineering Research, under the broad grouping of Medical Research and related organizations. As of 12/2021, Gardp North America Inc employed 2 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Gardp North America Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
TO OPERATE AND CONDUCT ACTIVITIES IN THE UNITED STATES THAT CONTRIBUTE TO THE DEVELOPMENT OF NEW HEALTH TECHNOLOGIES TO FIGHT AGAINST ANTIMICROBIAL RESISTANCE ("AMR") AND TO FOSTER APPROPRIATE USE AND ENHANCE ACCESS TO SUCH TECHNOLOGIES.
Describe the Organization's Program Activity:
Part 3 - Line 4a
GARDP NA WAS INCORPORATED IN MAY 2021. ACTIVITIES TO DATE HAVE INCLUDED INITIAL ORGANIZATIONAL MATTERS AND KICK OFF OF PROGRAMMATIC ACTIVITIES.GARDP NA HAS INITIATED THE FOLLOWING, CONSISTENT WITH OUR BUSINESS PLAN:1) INITIATED FUNDRAISING AND GRANT MAKING OUTREACH TO SUPPORT RESEARCH AND DEVELOPMENT ("R&D") AND OTHER PROGRAMS AIMED AT COMBATING ANTIMICROBIAL RESISTANCE;2) BEGAN RAISING AWARENESS OF AND FOSTERING PUBLIC APPRECIATION AND UNDERSTANDING OF ANTIMICROBIAL RESISTANCE AND ASSOCIATED PUBLIC HEALTH ISSUES AMONG POLICY MAKERS, THE MEDIA, AND PRIVATE SECTOR, CIVIL SOCIETY AND GOVERNMENTAL BODIES, THE GENERAL PUBLIC AND OTHER RELEVANT STAKEHOLDERS; RAISING AWARENESS OF THE NEED TO INVEST IN R&D AND SUSTAINABLE AND EQUITABLE ACCESS PROGRAMS IN THE FIELD OF ANTIMICROBIAL RESISTANCE, AND ADVOCATING FOR THE ADOPTION OF POLICIES FAVORABLE TO SUCH INVESTMENT IN THE FIELD OF ANTIMICROBIAL RESISTANCE, CONSISTENT WITH GARDP NA'S STATUS UNDER SECTION 501(C)(3) OF THE CODE AND SUBJECT TO THE APPLICABLE LIMITATIONS AND RESTRICTIONS UNDER THE CODE.3) SUPPORTED OTHER RELEVANT GLOBAL OR REGIONAL INITIATIVES IN PUBLIC HEALTH, WITH A FOCUS ON ANTIMICROBIAL RESISTANCE, INCLUDING COOPERATION WITH AND FACILITATION OF STRATEGIC AND COLLABORATIVE RELATIONSHIPS AMONG POLICYMAKERS, ACADEMIC AND RESEARCH INSTITUTIONS, DIAGNOSTIC, PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, PHILANTHROPIC INSTITUTIONS, CIVIL SOCIETY AND OTHER ORGANIZATIONS, WHETHER LOCAL, NATIONAL, OR INTERNATIONAL.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Jennifer Schneider Executive Officer & Treasurer | Officer | 40 | $112,677 |
Sara Cosgrove Chair | OfficerTrustee | 1 | $0 |
Vincent Constantin Secretary - Started 12/20/21 | Officer | 1 | $0 |
Jerome Oberreit Secretary Until 12/17/21 | Officer | 1 | $0 |
Jimmy Kolker Director | Trustee | 1 | $0 |
Paul Model Director - Started 12/20/21 | Trustee | 1 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $1,104,000 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $1,104,000 |
| Total Program Service Revenue | $0 |
| Investment income | $0 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $1,104,000 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $127,975 |
| Compensation of current officers, directors, key employees. | $76,785 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $0 |
| Pension plan accruals and contributions | $0 |
| Other employee benefits | $0 |
| Payroll taxes | $8,683 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $11,271 |
| Fees for services: Accounting | $0 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $61,979 |
| Advertising and promotion | $0 |
| Office expenses | $2,359 |
| Information technology | $2,895 |
| Royalties | $0 |
| Occupancy | $0 |
| Travel | $425 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $417 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $0 |
| Insurance | $7,342 |
| All other expenses | $0 |
| Total functional expenses | $223,346 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $126,405 |
| Savings and temporary cash investments | $0 |
| Pledges and grants receivable | $747,000 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $8,197 |
| Net Land, buildings, and equipment | $0 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $16,987 |
| Total assets | $898,589 |
| Accounts payable and accrued expenses | $17,935 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $17,935 |
| Net assets without donor restrictions | $133,654 |
| Net assets with donor restrictions | $747,000 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $898,589 |
Peer Organizations
| Organization Name | Assets | Revenue |
|---|---|---|
Foundation For The National Institute Of Health Inc North Bethesda, MD | $221,939,759 | $107,605,691 |
Masonic Medical Research Laboratory Utica, NY | $55,347,194 | $10,340,059 |
Narrows Institute Of Biomedical Research Inc Brooklyn, NY | $2,253,098 | $3,708,493 |
Cincinnati Education And Research For Veterans Foundation Cincinnati, OH | $2,556,475 | $1,534,256 |
Buffalo Institute For Medical Research Inc Buffalo, NY | $831,604 | $878,680 |
Gardp North America Inc Philadelphia, PA | $898,589 | $1,104,000 |
New Jersey Association For Biomedical Research Inc Atco, NJ | $468,818 | $179,812 |
Irving And Doris Gamow Stem Cell Research Institute Inc Ramsey, NJ | $1,209,679 | $55,799 |
International Society For Hyaluronan Sciences Wilmington, DE | $274,267 | $88,672 |
Biohacking Village Brooklyn, NY | $97,646 | $0 |
Chinese Biopharmaceutical Association-Usa Inc Potomac, MD | $713,657 | $140,026 |
Austen Bioinnovation Institute In Akron Akron, OH | $0 | -$8,075,738 |